Partner Content Partner Content Ipsen presents on oral peptides innovations, advances and de... Ipsen presents on oral peptides innovations & delivery
Partner Content Partner Content PLIVA explores impact of EU Guidelines on evaluation of modi... PLIVA explores EU Guidelines for modified release drugs
Events Partner Content 10th annual Adaptive Designs in Clinical Trials Adaptive Designs in Clinical Trials 2018
Partner Content Partner Content Agenda released for SMi Group’s Controlled Release Delivery ... Agenda released for Controlled Release Delivery 2018
Events Partner Content Controlled Release Delivery 2018 15th annual Controlled Release Delivery in London
Partner Content Partner Content Attendee list for Biosimilars North America 2017 released Attendee list for Biosimilars North America 2017 releas
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.